EPISODE · Jun 10, 2026 · 26 MIN
Why Pharma Is Taking Cannabis Seriously | Trade to Black
from The Dales Report | Trade to Black · host Dales Media Group
The spotlight turns to Toronto this week as Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) hosts its 6th Annual Clinical Symposium at the Mars Discovery District on June 12-13.In the latest Trade To Black Podcast, host Shadd Dales sits down with Avicanna CEO Aras Azadian to discuss why this year’s event comes at such an important time for the medical cannabis industry.With U.S. medical cannabis rescheduling now in place and pharmaceutical companies, healthcare providers, researchers, and institutional investors taking a closer look at cannabinoid-based medicine, the industry appears to be entering a very different phase than we’ve seen over the past decade.This year’s symposium will bring together leading clinicians, researchers, neurologists, pain specialists, veterans advocates, and healthcare professionals to discuss topics including PTSD, chronic pain, epilepsy, women’s health, prescribing frameworks, real-world evidence, patient outcomes, and the future of pharmaceutical-grade cannabinoid therapies.Shadd and Aras also discuss the growing interest coming from pharmaceutical companies, the significance of recent FDA developments involving cannabinoid-based therapies, and why many believe the United States is beginning to follow a path that Canada has spent years building.The conversation also touches on physician education, insurance coverage, clinical guidelines, research funding, and why many healthcare professionals believe cannabinoid medicine is approaching a pivotal moment.For anyone interested in learning more about the future of medical cannabis, cannabinoid-based medicine, clinical research, pharmaceutical-grade cannabinoids, and healthcare innovation, the Avicanna Clinical Symposium takes place this Thursday and Friday. If you’d like to attend virtually and watch the presentations live, click the link in the pinned comment section below.#Avicanna #MedicalCannabis #Cannabinoids #CannabisResearch #CBD #PTSD #CannabisMedicine #HealthcareInnovation #Pharmaceuticals #TradeToBlackWant to see more Cannabis Reform?🎬 • Trulieve Becomes First Cannabis MSO Approv... 🎬 • Cannabis Stocks Arrive On Robinhood | TDR ... 🎬 • Why Virginia’s Governor Really Vetoed Cann... 🎬 • IRS Tax Guidance Could Boost Cannabis Prof... Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook: / thedalesreport ✅ Twitter: / thedalesreport ✅ Instagram: / dalesreport ✅ LinkedIn: / the-dales-report Apple Podcasts: https://tinyurl.com/TDRTradetoBlackon...Spotify: https://tinyurl.com/TDRTradeToBlackon...Website: https://thedalesreport.com/For copyright matters, contact:[email protected] Disclaimer (Financial Interests)The views and opinions expressed in this podcast are those of the hosts and guests and do not necessarily reflect the official policy or position of any company, organization, or employer. The content is provided for informational and entertainment purposes only and should not be taken as financial, investment, or legal advice.The hosts and/or guests may hold positions in the companies, stocks, or financial instruments discussed during the show. These holdings should not be considered endorsements or recommendations to buy or sell any securities. Listeners are encouraged to do their own research or consult with a qualified financial advisor before making any investment decisions.By listening to this podcast, you agree that the hosts, guests, and producers are not liable for any decisions made based on the information discussed.Full Disclosures: https://thedalesreport.com/website-te...
Embed this episode
NOW PLAYING
Why Pharma Is Taking Cannabis Seriously | Trade to Black
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.